[1] 冯姣,曾梅华,陈军,等. 甲癣的病原学研究进展[J]. 中国真菌学杂志, 2013, 8(2): 120-123.
[2] 单敏洁,陈力,王晓华. 藿黄浸剂治疗角化型手足癣、甲癣的临床观察[J]. 四川中医, 2004(6): 74-76.
[3] 杨文喜. 温阳通痹汤加减治疗甲沟炎、甲真菌病20例[J]. 内蒙古中医药, 1998(S1): 1.
[4] 张会娜. 王萍扶正法治疗甲真菌病探析[J]. 中华中医药杂志, 2021, 36(6): 3407-3409.
[5] 陈月莹,吴玉莹,梁雪莲,等. 从六经辨证探讨甲癣的辨证分型[J]. 中国民族民间医药, 2021, 30(17): 7-9.
[6] 乔建军,张宏,石婧. 四种抗真菌药物治疗甲癣疗效比较的文献系统复习[J]. 中国皮肤性病学杂志, 2005(7): 419-421.
[7] 和艳琴. 伊曲康唑治疗甲癣疗效观察[J]. 皮肤病与性病, 2010, 32(1): 40-41.
[8] BUENO J, MARTINEZ C, ZAPATA B, et al. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis[J]. Clinical and Experimental Dermatology, 2010, 35(6): 658-663.
[9] 杨焕芝,李志伟,夏金凤,等. 伏立康唑治疗侵袭性真菌病临床疗效及其影响因素研究[J]. 中国药物评价, 2021, 38(1): 30-33.
[10] 陈丽华,朱红梅,温海. 甲真菌病治疗现状[J]. 中国真菌学杂志, 2012, 7(3): 188-192.
[11] ELEWSKI B,POLLAK R,ASHTON S, et al. A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis[J]. Br J Dermatol, 2012, 166(2): 389-398.
[12] 谢海伟,杨贤松,吕超田,等. 抗真菌药物及其作用机制研究[J]. 中国微生态学杂志, 2015, 27(12): 1477-1479,1488.
[13] 周渝敏,刘辽. 31例特比萘芬致不良反应的文献分析[J]. 中国医药指南, 2015, 13(21): 76-78.
[14] 特比萘芬临床应用专家共识工作组.特比萘芬临床应用专家共识[J]. 中国真菌学杂志, 2020, 15(5): 257-261.
[15] GUPTA A K,PAQUET M,SIMPSON F, et al. Terbinafine in the treatment of dermatophyte toenail onychomycosis: A meta-analysis of efficacy for continuous and intermittent regimens[J]. J Eur Acad Dermatol Venereol, 2013, 27(3): 267,272.
[16] ESCHENAUER G,DEPESTEL D,CARVER P. Comparison of echinocandin antifungals[J]. Ther Clin Risk Manag, 2007, 3(1): 71-97.
[17] CHEN S,SLAVIN M,SORRELL T. Echinocandin antifungal drugs in fungal infections: A comparison[J]. Drugs, 2011, 71(1): 11-41.
[18] GUPTA A,BARAN R. Ciclopirox nail lacquer solution 8% in the 21st century[J]. J Am Acad Dermatol, 2000, 43 (Suppl 4): S96-102.
[19] SHEMER A,NATHANSOHN N,TRAU H, et al. Ciclopirox nail lacquer for the treatment of onychomycosis: An open non-comparative study[J]. J Dermatol, 2010, 37(2): 137-139.
[20] 陈慧. 阿莫罗芬搽剂联合口服伊曲康唑与特比萘芬治疗甲真菌病临床观察[J]. 河北医学, 2015, 21(5): 761-763.
[21] 胡馨,王延龙,吕莎,等. 5%阿莫罗芬搽剂治疗68例远端侧位甲下型甲真菌病的临床疗效观察[J]. 中国真菌学杂志, 2021, 16(2): 90-95,112.
[22] TSCHEN E H, BUCKO A D, OIZUMI N, et al. Efinaconazole solution in the treatment of toenail onychomycosis: A phase 2, multicenter, randomized, double-blind study[J]. J Drugs Dermatol, 2013, 12(2): 186-192.
[23] JO W,GLYNN M,NEJISHIMA H, et al. Nonclinical safety assessment of efinaconazole solution (10%) for onychomycosis treatment[J]. Regul Toxicol Pharmacol, 2014, 70(1): 242-253.
[24] GUPTA A K,HALL S,ZANE L T, et al. Evaluation of the efficacy and safety of tavaborole topical solution, 5%, in the treatment of onychomycosis of the toenail in adults: A pooled analysis of an 8-week, post-study follow-up from two randomized phase 3 studies[J]. J Dermatolog Treat, 2018, 29(1): 44-48.
[25] FLORES F C,ROSSO R S,CRUZ L, et al. An innovative polysaccharide nanobased nail formulation for improvement of onychomycosis treatment[J]. Eur J Pharm Sci, 2017, 100: 56-63.DOI:10.1016/j.ejps.2016.12.043.
[26] WATANABE S,KISHIDA H,OKUBO A. Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase iii study[J]. J Dermatol, 2017, 44(7): 753-759.
[27] CAMPIONE E,PATERNò E J,COSTANZA G, et al. Tazarotene as alternative topical treatment for onychomycosis[J]. Drug Des Devel Ther, 2015, 9: 879-886.DOI:10.2147/DDDT.S69946.
[28] 于培,尤德渊. 甲真菌病的治疗现状及研究进展[J]. 实用医院临床杂志, 2013, 10(4): 211-214.
[29] 禚风麟,张蕊娜,王莉,等. 长脉冲nd:Yag 1064nm激光对红色毛癣菌生长及超微结构的影响[J]. 中国麻风皮肤病杂志, 2014(8): 4.
[30] 赖爱民. 长脉冲1064nm nd:Yag激光治疗甲真菌病有效性和安全性的研究[J]. 中国医学创新, 2016(12): 17-20.
[31] HOCHMAN L G. Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed nd:Yag 1064-nm laser[J]. J Cosmet Laser Ther, 2011, 13(1): 2-5.
[32] LEE S H, KIM S Y, DING W, et al. Impact of elevated CO2 and Naddition on bacteria, fungi, and archaea in a marsh ecosystem with various types of plants[J]. Appl Microbiol Biotechnol, 2015, 99(12): 5295-5305.
[33] 肖翠容,林雅燕,许秀宽,等. 超脉冲CO2点阵激光联合外用联苯苄唑乳膏治疗甲真菌病的临床疗效观察[J]. 临床合理用药杂志, 2021, 14(2): 4.
[34] KERAI L V,HILTON S,MAUGUERET M,et al. Uv-curable gels as topical nail medicines: In vivo residence, anti-fungal efficacy and influence of gel components on their properties[J]. Int J Pharm, 2016, 514(1): 244-254.
[35] 卢丽明,王熙军. 5-氨基酮戊酸光动力疗法治疗甲真菌病[J]. 中外医学研究, 2017, 15(12): 3.
[36] 向延卫,李苏,杨连娟,等. 复方透骨草溶液治疗角化过度型足癣临床观察[J]. 湖南中医药大学学报, 2015, 35(7): 38-39,59.
[37] 冯克中.中药外治手足癣,甲癣,角化型湿疹疗效观察[J].中国自然医学杂志, 2000(2):105-105.
[38] 史立勤. 中西医结合外治甲癣40例疗效观察[J]. 浙江中医杂志, 2011, 46(8): 587-587.
[39] 王中梅,张旭. 自拟冰醋酸治疗甲癣100例的临床研究[J]. 中国实用医药, 2011, 6(29): 2.
[40] 魏武洪. 中药增效剂配合30%冰醋酸治疗甲真菌病82例疗效观察[J]. 重庆医学, 2004, 33(1): 116-117.
[41] 柴文波,董建飞,吴晓霞,等. 中药抑皮肤癣菌的研究进展[J]. 中医学, 2021, 10(3): 352-357. |
